Effects of protein phosphatase inhibitor calyculin a on the postacrosomal protein serine/threonine phosphorylation state and acrosome reaction in boar spermatozoa incubated with a cAMP analog.
In order to reveal the involvement of the sperm postacrosomal region in the acrosome reaction, we examined the effects of the protein phosphatase inhibitor calyculin A on the postacrosomal protein serine/threonine phosphorylation state and acrosome morphology in boar spermatozoa incubated with a cAMP analog. Proteins were highly phosphorylated on the serine/threonine residues only in the postacrosomal region before incubation. After 90-min incubation without calyculin A, the protein phosphorylation state declined in the postacrosomal region irrespective of the capacitation state while it remained under the detectable level in the other regions of the sperm head. However, addition of calyculin A effectively suppressed the decline in protein phosphorylation state and increased an inactive form of protein phosphatase 1 in the postacrosomal region. On the other hand, this inhibitor had no influence on the protein phosphorylation state in the acrosome and equatorial segment. After incubation without calyculin A for 180 or 360 min, many spermatozoa exhibited acrosomal changes and loss that indicated occurrence of the acrosome reaction. However, addition of calyculin A significantly blocked these events. These results are consistent with our suggestion that postacrosomal serine/threonine-phosphorylated proteins are involved in suppression of the acrosome reaction in boar spermatozoa in vitro.
Adachi
Jun
J
Graduate School of Science and Technology, Kobe University, Kobe, Japan.
Tate
Shunsuke
S
Miyake
Masashi
M
Harayama
Hiroshi
H
D000177:Acrosome / Q000187:drug effects / Q000201:enzymology*; D020101:Acrosome Reaction / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D002751:Chlortetracycline / Q000494:pharmacology; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000378:metabolism; D004004:Dichlororibofuranosylbenzimidazole / Q000031:analogs & derivatives / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D008297:Male; D008387:Marine Toxins; D010080:Oxazoles / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D054645:Protein Phosphatase 1 / Q000037:antagonists & inhibitors*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012694:Serine / Q000378:metabolism; D034421:Sus scrofa; D013873:Thionucleotides / Q000494:pharmacology; D013912:Threonine / Q000378:metabolism
D004791:Enzyme Inhibitors; D008387:Marine Toxins; D010080:Oxazoles; D011500:Protein Synthesis Inhibitors; D013873:Thionucleotides; C071644:5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate; D013912:Threonine; D012694:Serine; D004004:Dichlororibofuranosylbenzimidazole; C059041:calyculin A; D000242:Cyclic AMP; D054645:Protein Phosphatase 1; D002751:Chlortetracycline